Côd QR

Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment

Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small-cell lung cancer (NSCLC) accounting for the majority of the cases. Despite advancements in targeted therapies and immunotherapies, many patients still rely on chemotherapy, highlighting the need for innovativ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Saqib Raza Khan, Daniel Breadner
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2025-03-01
Cyfres:Current Oncology
Pynciau:
lung cancer
bispecific antibodies
chemotherapy
tumor microenvironment
Mynediad Ar-lein:https://www.mdpi.com/1718-7729/32/4/206
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg